Biotech

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.

 CEO and co-founder of Immunai Noam Solomon.
WORKERS TAKE care of cannabis plants at a farm in central Israel,  late last year.

Israeli researchers develop SafeWax coating that could cut pesticide use by 50%

 Heart hologram and doctor, heart disease. Health care of the future. Modern Medical Science, Hi Tech Diagnostic Panel. Mixed medium, copy space

Arkin raises $100m for early-stage biotech fund

Automated pharmaceutical conveyor line, robotic arms handling medical vials

Israel's biotech moment: How science, data, and geopolitics are converging - opinion


EU Council and Parliament reach agreement to overhaul drug rules, speed patient access

The agreement grants companies launching new medicines eight years of data protection for trial results and one year of market protection.

Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30, 2018.

Midlife weight loss shows metabolic benefits but sparks brain inflammation in BGU - study

“Our findings show that losing weight in midlife is not a simple copy-and-paste of what works in young adulthood,” Alon Zemer said.

Weight Loss

Biotech between worlds: Jacob Licht's aliyah story - interview

A better question might be: For a couple who fell in love with Israel as teenagers, why did it take us so long to make aliyah?

JACOB LICHT, 56, from Silver Spring to Jerusalem, 2024.

Israeli woman's vision restored in world's first-ever 3D-printed cornea implant

The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution.

The surgery team working on the implant at Rambam Hospital in Haifa.

Jerusalem surges ahead: Aspiring to become Israel’s biotech capital

Jerusalem's biotech sector grows with $1.7B in investments and 150 companies. In June, the city will host the international medical hackathon MinDstart.

 Jerusalem from above.

Jerusalem as our biotech capital: The city’s ascent as an innovation hub - opinion

Jerusalem's transformation is the outcome of long-term strategic policy, targeted public investment, and a thriving academic ecosystem.

 Jerusalem from above.

Is former truck mechanic Tim Friede may be key in creating anti-venom biotech

Friede's subjected himself to over 200 snake bites.

 Cobra snake.

Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors

Dolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.

Tel Aviv startup Immunai aim to map the immune system

MNDL Bio wins award for the most innovative biotech solution in the Middle East

The startup company MNDL Bio has been named the winner of the Most Innovative Biotech Solution in the Middle East award.

 MNDL Bio

Phage virus discovered at Hebrew University named after fallen soldier

Phages are viruses that precisely target and kill bacteria, which can offer “a potential solution to the growing crisis of antibiotic resistance.”

 An aerial view of Hebrew University of Jerusalem's Mount Scopus campus.

The unique challenges integrating AI into biotechnology - opinion

According to Start-Up Nation Central (SNC), AI represents about 30% of Israel’s start-ups and attracts nearly half of total company funding.

 Artificial Intelligence Illustration